National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Cell. 2020 Jun 25;181(7):1696-1696.e1. doi: 10.1016/j.cell.2020.04.052.
The JAK-STAT pathway is an evolutionarily conserved signal transduction paradigm, providing mechanisms for rapid receptor-to-nucleus communication and transcription control. Discoveries in this field provided insights into primary immunodeficiencies, inherited autoimmune and autoinflammatory diseases, and hematologic and oncologic disorders, giving rise to a new class of drugs, JAK inhibitors (or Jakinibs).
JAK-STAT 通路是一种进化上保守的信号转导范例,为受体到细胞核的快速通讯和转录控制提供了机制。该领域的发现为原发性免疫缺陷、遗传性自身免疫和自身炎症性疾病以及血液学和肿瘤疾病提供了深入了解,并产生了一类新的药物,即 JAK 抑制剂(或 Jakinibs)。